FDA Classifies Baxter’s January HomeChoice Peritoneal Dialysis Cycler Field Corrective Action As A Class I Recall
Baxter Healthcare Corporation announced that the U.S. Food and Drug Administration (FDA) has classified Baxter's recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall...
(more...)
(more...)
